Abstract
The viral main protease (Mpro) from a novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a key enzyme essential for viral replication and has become an attractive target for antiviral drug development. The Mpro forms a functional dimer and exhibits a pH-dependent enzyme activity and dimerization. Here, we report a molecular dynamics (MD) investigation to gain insights into the structural stability of the enzyme dimer at neutral and acidic pH. Our data shows larger changes in structure of the protein with the acidic pH than that with the neutral pH. Structural analysis of MD trajectories reveals a substantial increase in intersubunit separation, the loss of domain contacts, binding free energy and interaction energy of the dimer which implies the protein instability and tendency of dimer dissociation at acidic pH. The loss in the interaction energy is mainly driven by electrostatic interactions. We have identified the intersubunit hydrogen-bonding residues involved in the decreased dimer stability. These findings may be helpful for rational drug design and target evaluation against COVID-19.
Keywords: pH effect, Mpro, Coronavirus, Main protease, Dimer, Molecular dynamics
Graphical abstract
1. Introduction
Coronaviruses (CoVs) infecting humans were first identified in 1947 [1]. CoVs are enveloped viruses consisting of single positive-strand RNA. They infect animals and human such as bats, pets, livestock, poultry, and humans. In humans, CoVs can cause not only severe respiratory disorders but also gastrointestinal, and neurological damages. CoVs belong to subfamily Coronavirinae of the family Coronaviridae. The Coronavirinae is subdivided into four genera alpha-, beta-, gamma- and deltacoronavirus (α-, β-, γ-, and δ-CoV) [2]; each genus is further divided into four lineage subgroups.
The first pandemic of severe acute respiratory syndrome from coronavirus (SARS-CoV) appeared in 2002 and ended in early 2004. The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) named as COVID-19, emerged in late 2019 and rapidly caused a global pandemic. The outbreak of COVID-19 has now become a global threat and detrimentally affected public health care emergency around the world. The SARS-CoV-2 has a ∼82% genome similarity to that of the SARS-CoV [3]. The SARS-CoV-2 belongs to the β-CoV group. The SARS-CoV-2 is the 7th human coronavirus (HCoV) discovered until now [4]. The other six HCoVs include HCoV-229, HCoV-OC43, HCoV-NL63, HCoV-HKU1, SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV) [5,6]. The SARS-CoV-2, SARS-CoV, HCoV-OC43, HCoV-HKU1 and MERS-CoV belong to the genus β-CoV while the HCoVs, HCoV-229E and HCoV-NL63, belong to the genus α-CoV [6]. The β-CoV is well known because it is highly lethal to human. The human CoVs is genetically closely related to bat CoVs such as tylonycteris bat coronavirus HKU4 (Bat CoV-HKU4) [7]. The origin of the virus is still a subject of debate. Analysis of the whole-genome sequence similarity indicates bats, a high probability of the original career, which are speculated to be primordial hosts for most CoV lineages [[7], [8], [9], [10]].
There is an urgent need to explore antiviral targets and effective drugs for the COVID-19. Identification of potential protein targets and biological mechanism of the viral pathogenic process is important for drug development [[11], [12], [13], [14]]. Among various protein targets of SARS-CoV-2, the main protease (Mpro) or 3-chymotrypsin (C)-like cysteine protease (3CLpro) is an attractive therapeutic target due to its key enzyme in the replication cycle of the virus [[15], [16], [17]]. The Mpro is functional as dimer [3,17,18]. The enzyme is highly conserved across various CoVs but mutation in Mpro appears lethal to the virus [3] which makes Mpro as a promising target for the development of a broad-spectrum of antivirals against coronaviruses. Many potent inhibitors for the SARS-CoV-2 Mpro have been proposed by in silico approaches [[19], [20], [21], [22]]. A significant number of crystal structures of coronavirus Mpro determined by X-ray diffraction provided mechanistic insights into protein function and facilitated drug development. From 3D structure of the SARS-CoV-2 Mpro, the two subunits are arranged almost perpendicular to one another as shown in Fig. 1A. Each subunit comprises the N-terminus (NT) and three domains (DM I, II and III) [3,17,23,24]. The NT or “N-finger” consists of residues ~1–9. The DM I and II encompass residues ~10–100 and ~101–182, respectively. The catalytic residues are in a cleft between these two domains. The DM III possessing residues ~200–300 is reported to be involved in the dimerization of Mpro. The DM II and III are linked together by a polypeptide loop. The overall structure of SARS-CoV-2 Mpro is very similar to SARS-CoV Mpro [25]. The SARS-CoV Mpro has 96.1% of sequence identity compared to the SARS-COV-2 Mpro (Table 1 ), suggesting a close evolutionary relationship with the SARS coronavirus from the first pandemic. The primary structure of Mpro from Bat CoV-HKU4 has a relatively lower sequence identity with 49.2% but 3D structure share highly conserved structural features and conserved active site (Fig. 1B).
Fig. 1.
(A) 3D structure of SARS-CoV-2 Mpro dimer (N-terminus, NT: yellow, DM I: orange, DM II: green, DM III: purple and loop: gray). (B) Structural superimposition of backbone Mpro monomer of SARS-CoV-2, SARS-CoV and Bat CoV-HKU4. (C) Schematic representation of protein domain structure and sequence alignment of the charged residues of CoVs Mpro. Charged residues, Arg, Lys, Asp and Glu are highlighted in blue, cyan, red and pink lines, respectively. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Table 1.
Summary of the Mpro structural models and simulation details.
| Model | pIa | UniProtKB accession number | Identityb (%) |
PDB code |
Resolution (Å) |
pH | Simulation times (ns) × runs |
|---|---|---|---|---|---|---|---|
| SARS-CoV-2 | 5.95 | P0DTD1 | 100 | 6Y2E | 1.75 | neutral | 100 × 3 |
| acidic | 100 × 3 | ||||||
| SARS-CoV | 6.22 | P0C6X7 | 96.1 | 2GX4 | 1.93 | neutral | 100 × 3 |
| acidic | 100 × 3 | ||||||
| Bat CoV-HKU4 | 6.17 | P0C6W3 | 49.2 | 4YO9 | 2.30 | neutral | 100 × 3 |
| acidic | 100 × 3 |
Note apI is the theoretical isoelectric point of a 3C-like proteinase monomer predicted from Expasy web server. b%identity of amino acid sequence with respect to that of the SARS-CoV-2 Mpro were computed by Supermatcher (www.bioinformatics.nl).
A number of studies proposed that the SARS-CoV-2 Mpro exhibits a pH-dependent proteolytic activity that is important in dimerization and therefore essential for enzyme catalysis [[26], [27], [28], [29]]. The crystal structures of the SARS-CoV Mpro dimer have been solved under different pH conditions and the optimum pH for the enzyme activity was observed to be pH 7.4 [26,28]. Sharma et al. [30] demonstrated that the SARS-CoV-2 Mpro is most stable at neutral pH whereas the protein destabilizes at acidic pH. Biochemical and biophysical characterization showed that the enzyme resists to thermal denaturation in a wide range of pH values (from 5 to 10) with preference to more basic pH [27]. The Mpro enzyme has a high content of acidic residues (Fig. 1C). From an isoelectric point calculation (Table 1), the SARS-CoV-2 Mpro molecule is negatively charged at a neutral pH. At a pH below the isoelectric point (pI) of the protein, this could influence the protein charge state which may subsequently alter the interactions and the stability of the enzyme. Since the dimerization is necessary for the enzymatic activity, changing the protonation state of the charged residues of the enzyme can significantly affect the stability of the protein dimer. However, interaction resulting from the affected residues in a reduced stability of the dimer is not fully understood. In this study, we employed a computational approach to gain insights into the effect of pH on the structure of protein dimers and to identify residues involved in dimer stability, especially those forming salt-bridge or hydrogen bond (Fig. 1C). For comparison, we carried out molecular dynamics (MD) simulations of the Mpro from SARS-CoV-2 [24], SARS-CoV [31] and Bat CoV-HKU4 [32]. The details of simulated systems are summarized in Table 1.
2. Materials and methods
2.1. Structure models and molecular dynamics simulations
Protein structures used in this study were taken from Protein Data Bank with PDB code as shown in Table 1. All simulations were carried out using dimer structure of CoV Mpro. The simulated systems were built using visual molecular dynamics (VMD) [33]. The protein models were solvated using the water model TIP3P and neutralized using 0.1 M NaCl solutions. Based on the pI values (Table 1), the Mpro protein carries a net negative charge at a neutral pH. Protonation states of the charged residues in the studied model systems were defined based on the pKa calculation of two pH conditions, in neutral, and in acidic solution. At neutral pH, the protonation states of ionizable residues in the proteins were assigned by comparing the pH values set to the system and the pKa values of amino acids predicted using PROPKA [34]. For the proteins at acidic pH, all negatively charged residues (Asp and Glu) are in protonated form since there is a difficulty in obtaining accurate structure-based pKa predictions for residues buried in protein interiors [35]. All simulated systems were run with a time step of 2 fs. Periodic boundary condition is applied with a box size of ~131 × 131 × 131 Å3. A distance cutoff of 12 Å was used for calculating nonbonded interactions. Electrostatic interactions were calculated with particle mesh Ewald summation via fast Fourier transform, including van der Waals interactions, with a switching distance of 10 Å. Langevin dynamics at a constant temperature of 298 K was used with a damping coefficient of 1 ps−1. The pressure was kept constant at 1 atm using the Nose ´−Hoover Langevin piston method, with a piston period of 200 fs and a damping time of 50 fs. Energy minimization was performed to remove bad contacts between atoms. Atomistic MD simulations of each Mpro system were performed for 100 ns with three independent runs, each with different starting (initial) velocities; average with 90% confidence intervals are reported. The CHARMM36 force field parameters were applied for proteins [36]. The MD simulations were performed with the program NAMD version 2.12 [37]. A summary of simulation systems is shown in Table 1.
2.2. MD trajectory analysis
The structure and dynamic properties of the studied model systems were calculated as follows: root-mean-square deviation (RMSD), root-mean-square-fluctuation (RMSF) per residue, radius of gyration (Rg), the solvent-accessible surface area (SASA), secondary structure content, intersubunit distance between residue pairs, inter-domain distance between subunits, intersubunit binding free energy and interaction energy and the hydrogen bond occupancy. Analysis of the trajectory was mainly carried out using the simulation periods of 80–100 ns and averaged over 3 runs for each simulation system. The RMSDs relative to the initial structure were calculated using backbone atoms. The RMSF per residue relative to the average structure were calculated based on Cα atoms. Rg and SASA of the dimer were computed using “measure” commands in VMD. The secondary structure content was obtained according to the secondary structure definition assigned by VMD. The hydrogen bond occupancy is the percentage of time that the hydrogen bond is observed during the trajectory. For analysis of hydrogen bond occupancy, the geometric criteria for distance and angle between the donor and acceptor heteroatoms were ≤ 3.5 Å and ≥ 120°, respectively. Analysis of the structural properties were achieved using TCL scripts in VMD [33]. The average distance between heteroatoms of interacting pairs was plotted using python scripts and gnuplot.
2.3. MM-GBSA binding free energy calculation
The molecular mechanic method combined with the generalized Born and surface area continuum solvation (MM-GBSA) were employed to estimate the binding free energy of Mpro dimer. This method has been widely used to assess the relative binding affinities between proteins and ligand as well as between protein molecules. In the MM-GBSA calculations, snapshots of the systems were extracted from the last 20 ns of MD trajectories, and the explicit water molecules and ions were removed. Binding free energy, ∆Gbind, that is responsible for the stabilization of dimer is defined by,
| (1) |
where solvation energy of dimer, ∆Gsolv Dimer, is subtracted with solvation energies of each monomer S and S′, ∆Gsolv S and ∆Gsolv S′, respectively. The difference in free energies between the dimer and monomer gives binding free energy. The free energy of each component is approximated by decomposing the energies into
| (2) |
| (3) |
| (4) |
where ΔE(gas) contains the internal energy, ΔE(int), electrostatic energy ΔE(elec) and van der Waals energy, ΔE(vdW), calculated in the gas phase. ΔG(solvation) is composed of the polar contribution, ΔG(GB) and the nonpolar contribution, ΔG(nonpolar). The ΔG(GB) was calculated using the generalized Born implicit solvent methods with the interior and exterior dielectric constants of 1 and 78.5, respectively. The ΔG(nonpolar) was calculated from the solvent-accessible surface-area (SASA). All parameters are use according to the previous work [38]. The -TΔS term was not included in this study due to the low accuracy for estimating the entropic contribution. All the MM-GBSA calculations were carried out by NAMD version 2.12 [37,39] using CHARMM36 force field parameters [36].
2.4. Nonbond interaction energy calculation
The interaction analysis provided detailed understanding regarding the interactions within the Mpro dimer at different pH conditions. To quantify the contribution of individual amino acid residues in the protein domains, nonbond interaction energy (EInter Nonb), including electrostatic (EInter Elec), van der Waals (EInter VdW) interaction energies and per-residue interaction energy were performed using the NamdEnergy plugin available in NAMD [37]. A distance cutoff of 12 Å was used [40]. The last 20 ns of MD trajectory for each simulation was used to compute the nonbonded interaction energy.
2.5. Principal component analysis
A principal component analysis (PCA) of the Cα atom fluctuations was performed to extract the concerted domain motions that are relevant for biological function. Prior to performing PCA, the set of conformations sampled from the last 40 ns (60–100 ns) of MD trajectories were aligned to its average structure to eliminate all translational and rotational motions. The principal components of the motions correspond to the eigenvectors of the Cα coordinate covariance matrices and the eigenvalues are the amplitude of the eigenvectors along multidimensional space. The displacements of Cα atoms of each eigenvector illustrate the concerted motions of the protein along each direction. PCA was performed using the WORDOM software [41]. The essential dynamics along the principal components were generated using VMD [33].
3. Results & discussion
3.1. Root-mean-square deviation
RMSD with respect to the starting structure was computed to illustrate the influence of pH on the dimer structure in each model system during the MD simulations (Fig. 2A). It should be noted that the RMSD has reached the plateau within the first 50 ns of the simulations for all studied systems, except for the acidic model system of Bat CoV-HKU4 whose RMSD continuously increases throughout the simulation. As judge by convergent RMSD values, we analyzed the trajectory of the last 20 ns to calculate structural information to identify the structural changes induced by the pH change.
Fig. 2.
(A) Time evolution of RMSD relative to the starting structures and (B) RMSF versus the residue index at neutral (green) and acidic (red) pH. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
The backbone RMSD relative to the starting structure (Fig. 2A) revealed that all neutral pH systems attained an equilibration with the fluctuation between 1.0 and 2.0 Å. On the other hand, the Mpro dimer under low pH environment exhibited a wider fluctuation with the RMSD between 2.0 and 5.0 Å. The fluctuation in structural deviation was larger in acidic pH than that at neutral pH. The proteins tend to undergo substantial structural changes after modifying the charge state of sidechain of ionizable residues from neutral to acidic pH. All the RMSD profiles suggest the Mpro dimer is less stable upon acidification. Based on our MD data, the enzyme maintained its dimeric structure better in the neutral solution with a significant loss of its dimer stability in the acidic solution.
Fig. 2B shows the RMSF plots i.e. the amplitude of backbone fluctuation of individual residue with respect to its average reference position. We can see that the RMSF of the three proteins at neutral pH are similar in corresponding regions while their flexibility at acidic pH increases substantially throughout the entire protein region (Fig. 2B). Two notable regions, excluding disordered N- and C-termini residues, show a high level of flexibility compared with other regions. These two regions comprise of residues ~47–51 and ~180–190. The former is in a loop between 2 short helices of DM I while the latter is in the long linker loop between DM II and DM III. The most notable change in RMSF from neutral to acidic pH was observed for DM III in SARS-CoV-2 and Bat CoV-HKU4 and DM I in SARS-CoV. For the SARS-CoV-2 system at acidic pH, the highly flexible residues (~210–270) in DM III are located on the four helices, three of which are exposed to aqueous environment.
To identify residues and domains and quantify their relative fluctuation, RMSD per-residue was evaluated as presented in Supplementary Fig. S1. We found that the magnitude of RMSD of almost all residues were higher on average with the acidic pH than that with the neutral pH. Consequently, the collective fluctuations of the initial positions of residues for each protein studied may result in higher fluctuations in all three domains when the pH changes from neutral to acidic pH. For example, large fluctuations (RMSD >4.5 Å) at low pH spanned across the protein particularly in the regions, including residues 47–52 in DM I, 164–172 in DM II and 186–193 in the loop (as shown by red contour in Supplementary Fig. S1). These regions contain ionizable residues (Supplementary Table S1) that are involved in formation/disruption of salt-bridges depending on the charged state of sidechain. We also notice from RMSD per-residue plots of SARS-CoV-2, SARS-CoV and Bat CoV-HKU4 that DM I and DM II have large effects at an early stage whereas DM III showed large conformational changes after ~20 ns of the simulation. While the acidity-induced structural changes appeared in DM I and DM II during entire timescale of present simulation, it showed at the later stage in DM III.
From a trajectory analysis, the total number of hydrogen bonds within each protein subunit remarkably decreased as pH change from neutral to low pH values (Supplementary Table S2). Such a change was associated with protonation of the carboxylate sidechain (glutamic acid and aspartic acid) that were engaged in inter-residue salt-bridge/hydrogen bond interactions within the protein. Although some charged residues are accessible to the solvent, oppositely charged residues are close to enough to form ionic pairs or salt bridges. The protonated sidechain on acid residues that is electrically neutral, disrupted these interactions due to the increased electrostatic repulsion with the positively charged groups. Note that the observed conformational changes occurred in the same regions in both subunits (S and S′), implying that the acid pH affects the monomer structure in similar fashion. Changes in the dimer structure and interaction energy in response to acidification will be discussed in further details later.
3.2. Structural properties
The influence of pH on the structural properties of Mpro dimer were further investigated by analyzing such quantities as radius of gyration (Rg), solvent accessible surface area (SASA) and the percentage of secondary structure segments using VMD TCL command scripts. The radius of gyration (Rg) of Mpro dimer was found to increase by changing to acidic pH from neutral, all variants of covid examined (Fig. 3A), i.e. conformation of the protein expanded by acidity. The solvent accessible surface area (SASA) of the Mpro also increased with acidity, more in SARS-CoV and Bat CoV-HKU4 than that in SARS-CoV-2 (Fig. 3B). This trend implies that the dimer structures in acidic pH are more accessible to the solvent which is consistent with the loss of compactness of the dimer in a low pH environment. Fig. 3C and D show the partial loss of secondary structure elements (β-strand or α-helix) in the Mpro dimer along the MD trajectories in acidic pH compared to that of the neutral system. We found that the partial disruption of the secondary structure was attributed mainly to β-strand. We noted that the DM I and II have the chymotrypsin-like double β-barrel fold structure whereas the DM III consists of five antiparallel α-helices. Thus, the loss of the β-strand secondary structure content occurred only in DM I and DM II but not in DM III (Fig. 1A). This implies that DM I and DM II are more susceptible to disruption of protein dimer upon acidification than DM III. Our MD results clearly show that a structure disruption of the Mpro dimer is induced by pH which supports the hypothesis of “pH-dependent conformational changes” by Tan et al. [28]. Our results are also in good agreement with experimental analysis on decreased enzyme stability under acidic pH [27].
Fig. 3.
Structural properties as a function of time at neutral versus acidic pH which are shown in green and red colors, respectively. (A) Radius of gyration (Rg). (B) Solvent-accessible surface area (SASA). (C and D) Percentage of α-helix and β-strand content, respectively. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
3.3. Intersubunit contact map
Intersubunit distance between residue pairs refer to contact between residues of one monomer (Mpro) with residues of another monomer of the dimer. Intersubunit contact maps showed the proximity between residues of the two monomers. They can be used to quantitatively evaluate the tendency of dimer dissociation. Contact maps presented in the 2-dimensional matrix (Fig. 4 ) of the protein dimer were based on the center-of-mass distance between intersubunit residues with 9 Å cut-off. At neutral pH, the dimer contacts of domains II-II, II-III and III-III are clearly visible, and their interactions are more numerous and stronger than those of domain — I-I, I-II and I-III. The pattern of the contact maps for SARS-CoV-2 and SARS-CoV is nearly identical, suggesting a very similar arrangement and spatial proximity of protein dimer. In addition, we observed strong contact for residues in the N-terminus and the DM II. The interactions between DM II and the NT of another subunit have been reported which suggests possible hydrogen bonding from the charged residues [3,24] that help control the correct orientation of binding site [[42], [43], [44]]. On the other hand, the residues of the Bat CoV-HKU4 Mpro possess much smaller number of intersubunit domain contacts implying that the enzyme has a weak compact structure compared to SARS-CoV-2 and SAR-CoV enzyme. In the acidic pH systems, we observed the same contact maps with a lighter intensity for the SARS-CoV Mpro. Especially, the separation distances for domains II-II, II-III and III-III became larger.
Fig. 4.
The intersubunit contact maps of Mpro dimer. Inter-residue distances were measured using the centers of mass of the two residue side chains. The x-axis (one monomer) and y-axis (second monomer) show the protein domains (DM I, DM II and DM III) which are scaled based on amino acid sequence.
The average separation between domain subunits of the dimer was calculated using the last 20 ns MD trajectories; quantitative estimates are presented in Table 2 . Overall, the separation between the same domains of the dimer, i.e. —I-I, II-II and III-III increased significantly as pH changes from neutral to acidic conditions, indicating that the two monomers moved apart further. To better understand the conformationally relevant motions of the proteins, we carried out a principal component analysis (PCA) of backbone fluctuations. MD snapshots of the last 40 ns were used to extract the dominant domain motions of the proteins. Fig. 5 illustrates the relevant collective motions of Cα atoms of SARS-Cov-2 Mpro projected along the first eigenvector. PCA analysis reveals a rigid body domain motion in both subunits. At acidic pH, the three domains of each monomer rotate relative to the central body of the dimer by swinging outward away from the C2 symmetric axis of the protein. In the concerted domain rotation, DM I and DM II move outward in the same direction whereas the movement of DM III is perpendicular to that of the first two domains. This motion creates a scissor-like motion away from the C2 axis (supplementary movies S1). Based on the outward scissoring movement, the displacement of protein domains results in a larger separation between monomers.
Table 2.
Inter-domain distance between monomers.
| System | DM I-DM I (Å) |
DM II-DM II (Å) |
DM III-DM III (Å) |
|||
|---|---|---|---|---|---|---|
| Neutral | Acidic | Neutral | Acidic | Neutral | Acidic | |
| SARS-CoV-2 | 43.6 ± 0.2 | 47.2 ± 0.5 | 28.4 ± 0.1 | 31.0 ± 0.3 | 32.8 ± 0.2 | 35.4 ± 0.7 |
| SARS-CoV | 43.8 ± 0.2 | 44.8 ± 0.4 | 28.0 ± 0.1 | 29.5 ± 0.2 | 32.6 ± 0.4 | 38.7 ± 0.7 |
| Bat CoV-HKU4 | 44.2 ± 0.3 | 43.3 ± 0.3 | 26.6 ± 0.1 | 28.2 ± 0.2 | 31.8 ± 0.5 | 45.1 ± 1.3 |
Fig. 5.
Essential dynamics of SARS-CoV-2 Mpro at acidic pH. The representation of collective motions with respect to PC1 was generated using the in-house VMD scripts. Arrows indicate the direction of domain motions in the protein. The colour changes from red-white-blue indicates time increasing from initial (at 60 ns) to end-time (at 100 ns). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
3.4. Binding free energy of dimer
To quantify the binding energy of the dimer in the two pH conditions, we performed binding free energy calculations using MM-GBSA in NAMD. The binding free energy (∆Gbind) that determines the stability of the dimer is shown in Fig. 6 . The calculated values of binding free energy of the SARS-CoV-2 Mpro dimer are −137.81 ± 5.64 kcal/mol at neutral pH and −70.28 ± 4.73 kcal/mol at acidic pH. The standard error is relatively small with respect to ∆Gbind, implying that the simulation length associated with binding free-energy calculations is sufficiently enough. A comparison of ∆Gbind values suggested that the SARS-CoV-2 Mpro dimer at a low pH value was markedly weaker than that at neutral pH. This indicated that the interactions of dimer tend to become weaker, resulting in a decrease in dimer stability under acidic conditions. It should be noted that the decreased dimer stability was also be observed in SARS-CoV (−110.33 ± 4.83 kcal/mol in neutral and −68.97 ± 3.96 kcal/mol in acid) and Bat CoV-HKU4 (−84.38 ± 4.80 kcal/mol in neutral and −60.87 ± 3.71 kcal/mol in acid). From the results, the Mpro exhibits the same pH-dependence of protein stability within the coronavirus family.
Fig. 6.

MM-GBSA calculated binding free energies (∆Gbind) of Mpro dimer. The data at neutral and acidic pH are shown in green and red colors, respectively. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
3.5. Dimer and domain interaction energy
To assess the contributions and their changes in the interactions within the Mpro dimer at different pH values, we computed the nonbonded interaction energy based on the molecular mechanic calculation using NamdEnergy Plugin. The nonbonded interaction can play a part in stabilizing protein since the structure stability is a result of a net balance of interactions within protein and between protein and solvent. We quantified the energetic contribution of particular interactions at the level of subunit-subunit and subunit-domain. The calculated energy of the nonbonded interaction within the protein is composed of electrostatic contributions and van der Waals interactions and cooperativity between the two nonbonded energies is critical to the stability. Fig. 7 shows intersubunit and interdomain nonbonded interaction energy together with electrostatic and van der Waals interaction energies. The graphs showed that the electrostatic interaction is a major contribution of the interaction energy. The van der Waals energy contribution appears to be relatively small and nearly equivalent to all systems. From a relative comparison, the electrostatic interactions play the dominant role in the dimer stability of the enzyme. For SARS-CoV-2 and SARS-CoV, the interaction energy between the two monomers of Mpro was attractive at neutral pH while a low pH value caused the intersubunit interaction to become more repulsive due to strong charge-charge repulsion (the positive energy values in Fig. 7A). We found that an increase of the electrostatic repulsion involved disruption of salt-bridge interactions in the protein. Apparently, the formation of a salt bridge strongly depends on the protonation state between two charged residues and thus on pH. A change in the protonation could generate large electrostatic effect to eliminate the salt-bridges and therefore destabilize the intersubunit and interdomain interactions of the protein. We also found that at neutral pH, the attractive interaction between subunit and domain I and III has a relatively large contribution to the net interaction energy (Fig. 7B-7D). The subunit-domain II interaction is relatively weak for SARS-CoV-2 and SARS-CoV but such interaction plays a significant role in the dimer stability of the Bat CoV-HKU4 enzyme.
Fig. 7.
Analysis of interaction energies (A) between two subunits (ES−S′Inter), (B) between subunit and DM I on another subunit (ES−SDM I′Inter), (C) between subunit and DM I on another subunit (ES−SDM II′Inter) and (D) between subunit and DM I on another subunit (ES−SDM III′Inter).
Further, per-residue interaction energy analysis of SARS-CoV-2 Mpro was performed to elucidate the contribution of important amino acids involved in the stability of the protein dimer. Per residue interaction energy (Eres−subunit Nonb) is computed based on the non-bonded molecular mechanic (MM) energy between all atoms of a given residue and all other atoms of another subunit. The per-residue energy plot showed that the N-terminal and DM III residues make significant contribution to the interaction energy of the dimer (Supplementary Fig. S2). From the energy plot, strong attractive (highly negative energy) interactions were found in residues Arg4, Lys12, Glu14, Glu288 and Glu290 at neutral pH (Fig. S2A). However, interactions of these residues became very weak attractive (near zero energy) or repulsive (highly positive energy) in acidic solution (Fig. S2B). It appears that most affected residues are charged residues which are located within 10 Å at the dimer interface. Particularly, Arg4, Lys12, Glu14 and Glu290 contribute significantly over other amino acids on the Mpro subunit toward the overall energy of dimer interactions.
3.6. Intersubunit hydrogen bond
Since the enzyme is functional in the dimeric form, the hydrogen bond of residue pairs between subunits plays a major role in the stability of the protein dimer. Analysis of intersubunit hydrogen bonds revealed residues involving domain interactions within the Mpro dimer. The presence and absence of Intersubunit hydrogen bonding upon a pH change from are mapped on the protein domains as shown in Fig. 8 , together with residue pairs involving in the interactions (Table 3 and Fig. 9 ). From the simulation of SARS-CoV-2, we found intersubunit-interdomain hydrogen bonds, involving residue pairs Ser1-Phe140’, Ser1-His172’, Ala7-Val125’ and Ser1-Glu166’ for NT-DM II interaction (Fig. 9B), Arg4-Glu290’ for NT-DM III interaction (Fig. 9C), Ser10-Ser10’, Glu14-Ser10’ and Glu14-Gly11’ for DM I-DM I interaction (Fig. 9D), and Ser139-Gln299’ for DM II-DM III interaction (Fig. 9E). The intersubunit and interdomain hydrogen bonds observed for SARS-CoV and Bat CoV-HKU4 Mpro were slightly different. These observed hydrogen bonds which are characterized as strong and moderate based on the high percent occupancy calculated from the trajectory data, contribute to the stability of the dimer. Strong hydrogen bond is defined as the percent hydrogen bond occupancy greater 80% while moderate and weak hydrogen bond are characterized by 40–80% and < 40% of the occupancy, respectively [40,45]. In the acidic pH, some residues show a loss of hydrogen bonds as well as contacts between subunits. These pairs of residues are: Ser1-His172’ and Ser1-Glu166’ for NT-DM II interaction, Arg4-Glu290' for NT-DM II interaction, Glu14-Ser10’ and Glu14-Lys12’ for DM I-DM I interaction, and Ser139-Glu299’ for DM II-DM III interaction (Table 3). As can be seen in Table 3 and Fig. 9B-9E, a disruption of most of these hydrogen bonds caused the enzyme being less stable in dimeric state at the acidic pH. As was evidenced by the larger separation distance between subunits and the loose compactness of dimer, a decline in the dimer stability must be associated with the loss of these hydrogen bonds. This loss has also substantially contributed to the loss in binding free energy (∆Gbind) and the interaction energy. Overall, our simulation results provide strong support for the decreased stability of the Mpro dimer at low pH condition.
Fig. 8.
Intersubunit hydrogen bond maps. Different shades of blue colour indicate strong, moderate and weak hydrogen bonds. Red cross symbols indicate the complete loss of hydrogen bond as pH is changed from neutral to acidic condition. Yellow star symbols indicate the interacting pair becomes weaker as the pH changes. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Table 3.
Summary of Intersubunit Hydrogen Bonda.
| Model | Inter-domain interaction | Residue pairs |
|
|---|---|---|---|
| Neutral | Acidic | ||
| SARS-CoV-2 | NT-DM II | Ser1-Phe140’, Ser1-His172’, Ala7-Val125’, Ser1-Glu166’ | Ser1-Phe140’, Ala7-Val125’ |
| NT-DM III | Arg4-Glu290 | – | |
| DM I-DM I | Ser10-Ser10’, Glu14-Ser10’ Glu14-Gly11’ | – | |
| DM II-DM III | Ser139-Glu299’ | – | |
| SARS-CoV | NT-DM II | Ser1-Ser139’, Ser1-His172’, Gly2-Ser139’, Ala7-Val125’ | Ser1-S139’, Ala7-Val125’ |
| NT-DM III | Arg4-Glu290’ | – | |
| DM I-DM I | Ser10-Ser10’, Glu14-Ser10’, Glu14-Gly11’ | – | |
| Bat CoV-HKU4 | NT-DM II | Ser1-Glu169’ | – |
| DM I-DM I | Ser10-Ser10’, Glu14-Ser10’, Glu14-Gly11’ | Ser10-Ser10’, Glu14-Gly11’ | |
Only hydrogen bonds with strong and moderate are included in the table.
Fig. 9.
The presence and absence of intersubunit hydrogen bonds within the SARS-CoV-2 Mpro. The neutral and acidic pH systems are represented in green and red colors, respectively. (A) Location of hydrogen-bonding residues in the protein and (B)-(E) highlighting hydrogen-bonding residues in the intersubunit and interdomain interaction sites. The prime symbol (‘) in text labels indicates amino acid residues of another subunit. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
It becomes clear that neutralization of the negatively charged residues of the protein in the acidic pH makes the overall interactions more repulsive. The repulsive interaction energy is mainly driven by electrostatic effects, eliminates salt-bridges in the protein dimer and hence destabilizes the dimer structure. However, the calculated binding free energy at acidic pH shown in Fig. 6 is still negative. This could be attributed to the solvation free energy that play the dominant contribution to binding free energy of the dimer.
An earlier study of pH-dependence SARS CoV-2 main protease showed structural stability during 250 ns MD simulation over the pH range 4 to 7 while the enzyme became unstable at pH 3 [46]. The main difference between this work and ours is the charge state of the proteins used in the simulations. In our protein model, acidic residues (Asp and Glu) have a neutral form at which the pH value was not explicitly given to our simulations in an acidic solution. This is because there is an argument for obtaining an accurate protonation state of the protein at a specific pH value using pKa calculations [35]. On the other hand, Barazorda-Ccahuana et al. used the protein with a different charge state at different pH depending on the prediction of pKa values of ionizable groups. This difference affects significantly to protein conformations which were generated from different initial protonation state of the protein. It should be noted that our protein has a closer value of the total charge to their protein at pH 3 where both proteins show similar instability. In addition, we analyzed the change in conformation around the S1 pocket which is implicated in substrate binding and protein dimerization. The Cα-atom distance of three pairs of residues including Cys145-His41, Met49-Gln189 and His172-Phe140, was used to estimate a change in the pocket volume of the protein. We found that the separation distance of residues Met49-Gln189 and His172-Phe140 increases remarkably (~5 Å) when the pH changes from neutral to acidic conditions (Supplementary Fig. S3). This result is consistent with an increased volume of the S1 pocket at pH 3 proposed by Barazorda-Ccahuana [46].
Previous theoretical and experimental studies have shown that the interaction involving the NT residue is important in dimer stability [3,43,[47], [48], [49], [50], [51]]. Especially, the strong hydrogen bond for the salt-bridge interaction between Arg4 of the NT and Glu290’ of the DM III found in both SARS-CoV-2 and SARS-CoV at neutral pH was not detected at acidic condition (Table 3 and Fig. 9). Hsu et al. proposed that the Arg4 in NT and residues in DM III are critical for stabilizing the Mpro dimer by maintaining a correct conformation of the active site [52]. Lowering the pH led to a decrease in the Mpro dimerization and activity [29]. Our simulations indicated that the Arg4-Glu290 hydrogen bond was not only involved in the observed decreased stability of Mpro dimer but intersubunit hydrogen-bonding residues of NT-DM II, DM I-DM I and DM II-DM III interactions should also be taken into consideration. The disruption of hydrogen bonds formed by these residues can interrupt enzyme dimerization, and thus this offers an alternative drug design approach to interfere the viral replication.
The discovery of potential repurposed antiviral agents has brought viral main protease, Mpro, to be an appealing therapeutic target for the treatment of COVID-19. Several available drugs targeting viral proteases such as HIV-1 and hepatitis C virus (HCV) protease inhibitors are currently being studied to test the safety and efficacy of the drug against this pandemic. As shown by x-ray crystallographic and biochemical studies, the FDA-approved anti-HCV drugs (boceprevir, narlaprevir and telaprevir) have been shown to effectively inhibit the enzyme by binding to the active site [53]. Since the enzyme is functional as dimer, a potential alternative mode of inhibition is to design inhibitors that bind efficiently to the charged residues critical for the dimer interaction. Our study showed that the interface-forming residues located in the N-terminus and DM III are capable of either disrupting the dimer or preventing dimer formation. The characteristics of subunit interface from this study can potentially be a novel site for drugs to interrupt the dimer formation as well as to reduce the stability of the Mpro.
4. Conclusions
Stability of the enzyme dimer was investigated in neutral and acidic solutions using MD simulations. The dimer stability was assessed by examining the loss of residue contacts, enhanced separation between the domains of protein monomers, reduced binding free energy and the interaction energy of the dimer in acidic medium in comparison to neutral environment. The structural fluctuation was larger in acidic pH than that with the neutral pH. Based on our MD data, the enzyme maintained its dimeric structure better in neutral pH condition with a substantial loss of its stability with acidic pH. Separation distance between domains (I, II, III) of one protein monomer and that of the second in the dimer was found to increase due to acidity. We have identified the residues that can stabilize the dimer conformation via hydrogen bonds of domains. The interactions of these residues may be helpful for rational drug design process against COVID-19.
The following are the supplementary data related to this article.
Notes
The authors declare no competing financial interest.
Credit author statement
Panisak Boonamnaj: Investigation, Methodology, Software, Original draft preparation.
Ras B. Pandey: Writing-Reviewing and Editing.
Pornthep Sompornpisut: Conceptualization, Validation, Writing- Reviewing and Editing, Supervision.
Declaration of Competing Interest
There are no conflicts of interest to declare.
Acknowledgements
P.S. is funded by Chulalongkorn University and this research is supported by Ratchadapisek Somphot Fund for Postdoctoral Fellowship, Chulalongkorn University to P.B.
Data availability
Data will be made available on request.
References
- 1.Pillaiyar T., Manickkam M., Namasivayam V., Hayashi Y., Jung S.-H. An overview of severe acute respiratory syndrome–coronavirus (SARS-CoV) 3CL protease inhibitors: Peptidomimetics and small molecule chemotherapy. J. Med. Chem. 2016;59:6595–6628. doi: 10.1021/acs.jmedchem.5b01461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Pal M., Berhanu G., Desalegn C., Kandi V. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update. Cureus. 2020;12:e7423. doi: 10.7759/cureus.7423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Goyal B., Goyal D. Targeting the dimerization of the main protease of coronaviruses: a potential broad-spectrum therapeutic strategy. ACS Comb. Sci. 2020;22:297–305. doi: 10.1021/acscombsci.0c00058. [DOI] [PubMed] [Google Scholar]
- 4.Ionescu M.I. An overview of the crystallized structures of the SARS-CoV-2. Protein J. 2020;39:600–618. doi: 10.1007/s10930-020-09933-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Li X., Luk H., Lau S., Woo P. Human coronaviruses: general features. Ref. Mod. Biomed. Sci. 2019 doi: 10.1016/B978-0-12-801238-3.95704-0. [DOI] [Google Scholar]
- 6.Liu D.X., Liang J.Q., Fung T.S. In: Encyclopedia of Virology. 4th ed. Bamford D.H., Zuckerman M., editors. Academic Press: Oxford; 2021. Human coronavirus-229E, -OC43, -NL63, and -HKU1 (Coronaviridae) pp. 428–440. [Google Scholar]
- 7.Zhou Z., Qiu Y., Ge X. The taxonomy, host range and pathogenicity of coronaviruses and other viruses in the Nidovirales order. Anim Dis. 2021;1:5. doi: 10.1186/s44149-021-00005-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Cui J., Li F., Shi Z.-L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019;17:181–192. doi: 10.1038/s41579-018-0118-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Li X., Song Y., Wong G., Cui J. Bat origin of a new human coronavirus: there and back again. Sci. China Life Sci. 2020;63:461–462. doi: 10.1007/s11427-020-1645-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Singh J., Pandit P., McArthur A.G., Banerjee A., Mossman K. Evolutionary trajectory of SARS-CoV-2 and emerging variants. Virol. J. 2021;18:166. doi: 10.1186/s12985-021-01633-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.González-Paz L., Hurtado-León M.L., Lossada C., Fernández-Materán F.V., Vera-Villalobos J., Loroño M., Paz J.L., Jeffreys L., Alvarado Y.J. Comparative study of the interaction of ivermectin with proteins of interest associated with SARS-CoV-2: a computational and biophysical approach. Biophys. Chem. 2021;278 doi: 10.1016/j.bpc.2021.106677. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Mukherjee S., Bhattacharyya D., Bhunia A. Host-membrane interacting interface of the SARS coronavirus envelope protein: immense functional potential of C-terminal domain. Biophys. Chem. 2020;266 doi: 10.1016/j.bpc.2020.106452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Chakraborty H., Bhattacharjya S. Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics. Biophys. Chem. 2020;265 doi: 10.1016/j.bpc.2020.106438. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Gordon D.E., Jang G.M., Bouhaddou M., Xu J., Obernier K., White K.M., O’Meara M.J., Rezelj V.V., Guo J.Z., Swaney D.L., Tummino T.A., Hüttenhain R., Kaake R.M., Richards A.L., Tutuncuoglu B., Foussard H., Batra J., Haas K., Modak M., Kim M., Haas P., Polacco B.J., Braberg H., Fabius J.M., Eckhardt M., Soucheray M., Bennett M.J., Cakir M., McGregor M.J., Li Q., Meyer B., Roesch F., Vallet T., Kain A.M., Miorin L., Moreno E., Naing Z.Z.C., Zhou Y., Peng S., Shi Y., Zhang Z., Shen W., Kirby I.T., Melnyk J.E., Chorba J.S., Lou K., Dai S.A., Barrio-Hernandez I., Memon D., Hernandez-Armenta C., Lyu J., Mathy C.J.P., Perica T., Pilla K.B., Ganesan S.J., Saltzberg D.J., Rakesh R., Liu X., Rosenthal S.B., Calviello L., Venkataramanan S., Liboy-Lugo J., Lin Y., Huang X.-P., Liu Y., Wankowicz S.A., Bohn M., Safari M., Ugur F.S., Koh C., Savar N.S., Tran Q.D., Shengjuler D., Fletcher S.J., O’Neal M.C., Cai Y., Chang J.C.J., Broadhurst D.J., Klippsten S., Sharp P.P., Wenzell N.A., Kuzuoglu-Ozturk D., Wang H.-Y., Trenker R., Young J.M., Cavero D.A., Hiatt J., Roth T.L., Rathore U., Subramanian A., Noack J., Hubert M., Stroud R.M., Frankel A.D., Rosenberg O.S., Verba K.A., Agard D.A., Ott M., Emerman M., Jura N., Zastrow M., Verdin E., Ashworth A., Schwartz O., Enfert C., Mukherjee S., Jacobson M., Malik H.S., Fujimori D.G., Ideker T., Craik C.S., Floor S.N., Fraser J.S., Gross J.D., Sali A., Roth B.L., Ruggero D., Taunton J., Kortemme T., Beltrao P., Vignuzzi M., García-Sastre A., Shokat K.M., Shoichet B.K., Krogan N.J. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583:459–468. doi: 10.1038/s41586-020-2286-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Hidalgo P., Valdés M., González R.A. Molecular biology of coronaviruses: an overview of virus-host interactions and pathogenesis. Bol. Med. Hosp. Infant. Mex. 2021;78:41–58. doi: 10.24875/BMHIM.20000249. [DOI] [PubMed] [Google Scholar]
- 16.Mengist H.M., Dilnessa T., Jin T. Structural basis of potential inhibitors targeting SARS-CoV-2 main protease. Front. Chem. 2021;9:7. doi: 10.3389/fchem.2021.622898. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Xia B., Kang X. Activation and maturation of SARS-CoV main protease, Protein. Cell. 2011;2:282–290. doi: 10.1007/s13238-011-1034-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Chen H., Wei P., Huang C., Tan L., Liu Y., Lai L. Only one protomer is active in the dimer of SARS 3C-like proteinase. J. Biol. Chem. 2006;281:13894–13898. doi: 10.1074/jbc.M510745200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Kavitha K., Sivakumar S., Ramesh B. 1,2,4 triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 main protease inhibitors: in silico screening and molecular dynamics simulation of potential COVID-19 drug candidates. Biophys. Chem. 2020;267 doi: 10.1016/j.bpc.2020.106478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Banerjee S. An insight into the interaction between α-ketoamide- based inhibitor and coronavirus main protease: a detailed in silico study. Biophys. Chem. 2021;269 doi: 10.1016/j.bpc.2020.106510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Shaji D., Yamamoto S., Saito R., Suzuki R., Nakamura S., Kurita N. Proposal of novel natural inhibitors of severe acute respiratory syndrome coronavirus 2 main protease: molecular docking and ab initio fragment molecular orbital calculations. Biophys. Chem. 2021;275 doi: 10.1016/j.bpc.2021.106608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Rao P., Shukla A., Parmar P., Rawal R.M., Patel B., Saraf M., Goswami D. Reckoning a fungal metabolite, Pyranonigrin a as a potential Main protease (Mpro) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation. Biophys. Chem. 2020;264 doi: 10.1016/j.bpc.2020.106425. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Yang H., Yang M., Ding Y., Liu Y., Lou Z., Zhou Z., Sun L., Mo L., Ye S., Pang H., Gao G.F., Anand K., Bartlam M., Hilgenfeld R., Rao Z. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc. Natl. Acad. Sci. U. S. A. 2003;100:13190–13195. doi: 10.1073/pnas.1835675100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S., Rox K., Hilgenfeld R. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science. 2020;368:409–412. doi: 10.1126/science.abb3405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Griffin J.W.D. SARS-CoV and SARS-CoV-2 main protease residue interaction networks change when bound to inhibitor N3. J. Struct. Biol. 2020;211 doi: 10.1016/j.jsb.2020.107575. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Huang C., Wei P., Fan K., Liu Y., Lai L. 3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism. Biochemistry. 2004;43:4568–4574. doi: 10.1021/bi036022q. [DOI] [PubMed] [Google Scholar]
- 27.Ferreira J.C., Rabeh W.M. Biochemical and biophysical characterization of the main protease, 3-chymotrypsin-like protease (3CLpro) from the novel coronavirus SARS-CoV 2. Sci. Rep. 2020;10:22200. doi: 10.1038/s41598-020-79357-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Tan J., Verschueren K.H.G., Anand K., Shen J., Yang M., Xu Y., Rao Z., Bigalke J., Heisen B., Mesters J.R., Chen K., Shen X., Jiang H., R. Hilgenfeld, pH-dependent conformational flexibility of the SARS-CoV main proteinase (Mpro) dimer: molecular dynamics simulations and multiple X-ray structure analyses. J. Mol. Biol. 2005;354:25–40. doi: 10.1016/j.jmb.2005.09.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Chou C.-Y., Chang H.-C., Hsu W.-C., Lin T.-Z., Lin C.-H., Chang G.-G. Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease. Biochemistry. 2004;43:14958–14970. doi: 10.1021/bi0490237. [DOI] [PubMed] [Google Scholar]
- 30.Sharma S., Deep S. pH effect on the dynamics of SARS-CoV-2 main protease (Mpro) bioRxiv. 2020 doi: 10.1101/2020.11.30.404384. [DOI] [Google Scholar]
- 31.Yang S., Chen S.-J., Hsu M.-F., Wu J.-D., Tseng C.-T.K., Liu Y.-F., Chen H.-C., Kuo C.-W., Wu C.-S., Chang L.-W., Chen W.-C., Liao S.-Y., Chang T.-Y., Hung H.-H., Shr H.-L., Liu C.-Y., Huang Y.-A., Chang L.-Y., Hsu J.-C., Peters C.J., Wang A.H.-J., Hsu M.-C., et al. Synthesis, crystal structure, structure−activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor. J. Med. Chem. 2006;49:4971–4980. doi: 10.1021/jm0603926. [DOI] [PubMed] [Google Scholar]
- 32.St S.E., John S., Tomar S.R., Stauffer A.D. Mesecar. Targeting zoonotic viruses: structure-based inhibition of the 3C-like protease from bat coronavirus HKU4—the likely reservoir host to the human coronavirus that causes middle east respiratory syndrome (MERS) Bioorg. Med. Chem. 2015;23:6036–6048. doi: 10.1016/j.bmc.2015.06.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Humphrey W., Dalke A., Schulten K. VMD: visual molecular dynamics. J. Mol. Graph. 1996;14:33–38. doi: 10.1016/0263-7855(96)00018-5. [DOI] [PubMed] [Google Scholar]
- 34.Li H., Robertson A.D., Jensen J.H. Very fast empirical prediction and rationalization of protein pKa values. Proteins. 2005;61:704–721. doi: 10.1002/prot.20660. [DOI] [PubMed] [Google Scholar]
- 35.Williams S.L., Blachly P.G., McCammon J.A. Measuring the successes and deficiencies of constant pH molecular dynamics: a blind prediction study, proteins: Struct. Funct. Genet. 2011;79:3381–3388. doi: 10.1002/prot.23136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Huang J., MacKerell A.D., Jr. CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. J. Comput. Chem. 2013;34:2135–2145. doi: 10.1002/jcc.23354. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Phillips J.C., Braun R., Wang W., Gumbart J., Tajkhorshid E., Villa E., Chipot C., Skeel R.D., Kale L., Schulten K. Scalable molecular dynamics with NAMD. J. Comput. Chem. 2005;26:1781–1802. doi: 10.1002/jcc.20289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Taweechat P., Pandey R.B., Sompornpisut P. Conformation, flexibility and hydration of hyaluronic acid by molecular dynamics simulations. Carbohydr. Res. 2020;493 doi: 10.1016/j.carres.2020.108026. [DOI] [PubMed] [Google Scholar]
- 39.Tanner D.E., Chan K.-Y., Phillips J.C., Schulten K. Parallel generalized born implicit solvent calculations with NAMD. J. Chem. Theory Comput. 2011;7:3635–3642. doi: 10.1021/ct200563j. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Boonamnaj P., Pandey R.B., Sompornpisut P. Interaction fingerprint of transmembrane segments in voltage sensor domains. Biophys. Chem. 2021;277 doi: 10.1016/j.bpc.2021.106649. [DOI] [PubMed] [Google Scholar]
- 41.Seeber M., Cecchini M., Rao F., Settanni G., Caflisch A. Wordom: a program for efficient analysis of molecular dynamics simulations. Bioinformatics. 2007;23:2625–2627. doi: 10.1093/bioinformatics/btm378. [DOI] [PubMed] [Google Scholar]
- 42.Chen S., Chen L., Tan J., Chen J., Du L., Sun T., Shen J., Chen K., Jiang H., Shen X. Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization: biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations. J. Biol. Chem. 2005;280:164–173. doi: 10.1074/jbc.M408211200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Chen S., Zhang J., Hu T., Chen K., Jiang H., Shen X. Residues on the dimer interface of SARS coronavirus 3C-like protease: dimer stability characterization and enzyme catalytic activity analysis. J. Biochem. 2008;143:525–536. doi: 10.1093/jb/mvm246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Cheng S.-C., Chang G.-G., Chou C.-Y. Mutation of Glu-166 blocks the substrate-induced dimerization of SARS coronavirus main protease. Biophys. J. 2010;98:1327–1336. doi: 10.1016/j.bpj.2009.12.4272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Helabad M.B., Volkenandt S., Imhof P. Molecular dynamics simulations of a chimeric androgen receptor protein (SPARKI) confirm the importance of the dimerization domain on DNA binding specificity. Front. Mol. Biosci. 2020;7:4. doi: 10.3389/fmolb.2020.00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Barazorda-Ccahuana H.L., Nedyalkova M., Mas F., Madurga S. Unveiling the effect of low ph on the SARS-COV-2 main protease by molecular dynamics simulations. Polymers. 2021;13:3823. doi: 10.3390/polym13213823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Lin P.-Y., Chou C.-Y., Chang H.-C., Hsu W.-C., Chang G.-G. Correlation between dissociation and catalysis of SARS-CoV main protease. Arch. Biochem. Biophys. 2008;472:34–42. doi: 10.1016/j.abb.2008.01.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Shi J., Sivaraman J., Song J. Mechanism for controlling the dimer-monomer switch and coupling dimerization to catalysis of the severe acute respiratory syndrome coronavirus 3C-like protease. J. Virol. 2008;82:4620–4629. doi: 10.1128/JVI.02680-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Chen S., Hu T., Zhang J., Chen J., Chen K., Ding J., Jiang H., Shen X. Mutation of Gly-11 on the dimer interface results in the complete crystallographic dimer dissociation of severe acute respiratory syndrome coronavirus 3C-like protease: crystal structure with molecular dynamics simulations. J. Biol. Chem. 2008;283:554–564. doi: 10.1074/jbc.M705240200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Hu T., Zhange Y., Li L., Wang K., Chen S., Chen J., Ding J., Jiang H., Shen X. Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure. Virology. 2009;388:324–334. doi: 10.1016/j.virol.2009.03.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Kneller D.W., Philips G., Weiss K.L., Pant S., Zhang Q., O'Neill H.M., Coates L., Kovalevsky A. Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography. J. Biol. Chem. 2020;295:17365–17373. doi: 10.1074/jbc.AC120.016154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Hsu W.-C., Chang H.-C., Chou C.-Y., Tsai P.-J., Lin P.-I., Chang G.-G. Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease. J. Biol. Chem. 2005;280:22741–22748. doi: 10.1074/jbc.M502556200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Kneller D.W., Galanie S., Phillips G., O'Neill H.M., Coates L., Kovalevsky A. Malleability of the SARS-CoV-2 3CL Mpro active-site cavity facilitates binding of clinical antivirals. Structure. 2020;28:1313–1320.e3. doi: 10.1016/j.str.2020.10.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Data will be made available on request.









